These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 27554244
1. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients. Stam-Slob MC, Visseren FL, Wouter Jukema J, van der Graaf Y, Poulter NR, Gupta A, Sattar N, Macfarlane PW, Kearney PM, de Craen AJ, Trompet S. Clin Res Cardiol; 2017 Jan; 106(1):58-68. PubMed ID: 27554244 [Abstract] [Full Text] [Related]
2. Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes Study. Kaasenbrood L, Poulter NR, Sever PS, Colhoun HM, Livingstone SJ, Boekholdt SM, Pressel SL, Davis BR, van der Graaf Y, Visseren FL, CARDS, ALLHAT, and ASCOT Investigators. Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):213-21. PubMed ID: 27174798 [Abstract] [Full Text] [Related]
3. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study. Waheed S, Pollack S, Roth M, Reichek N, Guerci A, Cao JJ. Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004 [Abstract] [Full Text] [Related]
4. Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry. Nanna MG, Navar AM, Wang TY, Mi X, Virani SS, Louie MJ, Lee LV, Goldberg AC, Roger VL, Robinson J, Peterson ED. J Am Heart Assoc; 2018 May 08; 7(10):. PubMed ID: 29739801 [Abstract] [Full Text] [Related]
5. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines. Mahabadi AA, Möhlenkamp S, Lehmann N, Kälsch H, Dykun I, Pundt N, Moebus S, Jöckel KH, Erbel R, Heinz Nixdorf Recall Study Investigators. JACC Cardiovasc Imaging; 2017 Feb 08; 10(2):143-153. PubMed ID: 27665163 [Abstract] [Full Text] [Related]
14. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS). Ota T, Ishii H, Suzuki S, Shibata Y, Tatami Y, Harata S, Shimbo Y, Takayama Y, Tanaka A, Kawamura Y, Osugi N, Maeda K, Kondo T, Murohara T. Atherosclerosis; 2015 Sep 08; 242(1):155-60. PubMed ID: 26188539 [Abstract] [Full Text] [Related]
15. Inception and deprescribing of statins in people aged over 80 years: cohort study. Gulliford M, Ravindrarajah R, Hamada S, Jackson S, Charlton J. Age Ageing; 2017 Nov 01; 46(6):1001-1005. PubMed ID: 29088364 [Abstract] [Full Text] [Related]
17. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort. Bai JW, Boulet G, Halpern EM, Lovblom LE, Eldelekli D, Keenan HA, Brent M, Paul N, Bril V, Cherney DZ, Weisman A, Perkins BA. Cardiovasc Diabetol; 2016 Jan 25; 15():14. PubMed ID: 26809442 [Abstract] [Full Text] [Related]